The role of PPARalpha in lipid metabolism and obesity: focusing on the effects of estrogen on PPARalpha actions.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Pharmacological Research

• Publication date

  2009-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.phrs.2009.02.004PMID 19646654
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study].

  2010cited by this paper
• Multiple Benign Symmetric Lipomatosis—A Differential Diagnosis of Obesity. Is There a Rationale for Fibrate Treatment?

  2008cited by this paper
• The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats.

  2008cited by this paper
• Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.

  2008cited by this paper
• Metabolic Actions of Estrogen Receptor Beta (ERβ) are Mediated by a Negative Cross-Talk with PPARγ

  2008cited by this paper
• Quantitative image analysis in adipose tissue using an automated image analysis system: Differential effects of peroxisome proliferator‐activated receptor‐α and ‐γ agonist on white and brown adipose tissue morphology in AKR obese and db/db diabetic mice

  2007cited by this paper
• Inhibition of the actions of peroxisome proliferator-activated receptor alpha on obesity by estrogen.

  2007cited by this paper
• PPAR agonists and the metabolic syndrome.

  2007cited by this paper
• Leptin Stimulates Fatty Acid Oxidation and Peroxisome Proliferator-Activated Receptor α Gene Expression in Mouse C2C12 Myoblasts by Changing the Subcellular Localization of the α2 Form of AMP-Activated Protein Kinase

  2007cited by this paper
• Thermogenic and metabolic antiobesity drugs: rationale and opportunities

  2007cited by this paper
• Inhibition of the Actions of Peroxisome Proliferator‐activated Receptor α on Obesity by Estrogen

  2007cited by this paper
• Peroxisome proliferator-activated receptor (PPAR) in metabolic syndrome and type 2 diabetes mellitus.

  2007cited by this paper
• Overexpression of uncoupling protein 3 in skeletal muscle protects against fat-induced insulin resistance.

  2007cited by this paper
• Is there a role for fibrates in the management of dyslipidemia in the metabolic syndrome?

  2007cited by this paper
• Peroxisome proliferator-activated receptor-alpha selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice.

  2006cited by this paper
• PPARα and PPARγ dual agonists for the treatment of type 2 diabetes and the metabolic syndrome

  2006cited by this paper
• Peroxisome proliferator-activated receptor-α selective ligand reduces adiposity, improves insulin sensitivity and inhibits atherosclerosis in LDL receptor-deficient mice

  2006cited by this paper
• PPARalpha and PPARgamma dual agonists for the treatment of type 2 diabetes and the metabolic syndrome.

  2006cited by this paper
• AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

  2006cited by this paper
• Modulation of fatty acid metabolism as a potential approach to the treatment of obesity and the metabolic syndrome

  2006cited by this paper
• Peroxisome proliferator-activated receptor alpha physically interacts with CCAAT/enhancer binding protein (C/EBPbeta) to inhibit C/EBPbeta-responsive alpha1-acid glycoprotein gene expression.

  2005cited by this paper
• PPARs: therapeutic targets for metabolic disease.

  2005cited by this paper
• Peroxisome Proliferator-Activated Receptor α Physically Interacts with CCAAT/Enhancer Binding Protein (C/EBPβ) to Inhibit C/EBPβ-Responsive α1-Acid Glycoprotein Gene Expression

  2005cited by this paper
• Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats.

  2005cited by this paper
• Fenofibrate prevents obesity and hypertriglyceridemia in low-density lipoprotein receptor-null mice.

  2004cited by this paper
• PPARs and the complex journey to obesity

  2004cited by this paper
• Benzafibrate induces acyl-CoA oxidase mRNA levels and fatty acid peroxisomal β-oxidation in rat white adipose tissue

  2004cited by this paper
• The brown adipocyte: update on its metabolic role.

  2004cited by this paper
• Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.

  2004cited by this paper
• Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha).

  2004cited by this paper
• Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice.

  2004cited by this paper
• Oleoylethanolamide Stimulates Lipolysis by Activating the Nuclear Receptor Peroxisome Proliferator-activated Receptor α (PPAR-α)*

  2004cited by this paper
• Peroxisome proliferator-activated receptors as attractive antiobesity targets.

  2004cited by this paper
• Increased fatty acid oxidation in transgenic mice overexpressing UCP3 in skeletal muscle

  2003cited by this paper
• Murine models to investigate pharmacological compounds acting as ligands of PPARs in dyslipidemia and atherosclerosis.

  2003cited by this paper
• Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α

  2003cited by this paper
• Isozyme-nonselective N-Substituted Bipiperidylcarboxamide Acetyl-CoA Carboxylase Inhibitors Reduce Tissue Malonyl-CoA Concentrations, Inhibit Fatty Acid Synthesis, and Increase Fatty Acid Oxidation in Cultured Cells and in Experimental Animals*

  2003cited by this paper
• The effects of K-111, a new insulin-sensitizer, on metabolic syndrome in obese prediabetic rhesus monkeys.

  2003cited by this paper
• Advances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and disease

  2003cited by this paper
• Fenofibrate improves lipid metabolism and obesity in ovariectomized LDL receptor-null mice.

  2003cited by this paper
• Human uncoupling protein-3 and obesity: an update.

  2003cited by this paper
• Fibrate treatment does not modify the expression of acyl coenzyme A oxidase in human liver

  2002cited by this paper
• Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis

  2002cited by this paper
• Fenofibrate regulates obesity and lipid metabolism with sexual dimorphism

  2002cited by this paper
• LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.

  2002cited by this paper
• Signal cross-talk between estrogen receptor alpha and beta and the peroxisome proliferator-activated receptor gamma1 in MDA-MB-231 and MCF-7 breast cancer cells.

  2002cited by this paper
• Effects of physical training on body composition and organ weights in ovariectomized and hyperestrogenic rats

  2002cited by this paper
• Identification of Rev-erbalpha as a physiological repressor of apoC-III gene transcription.

  2002cited by this paper
• Mechanism for Peroxisome Proliferator-activated Receptor-α Activator-induced Up-regulation of UCP2 mRNA in Rodent Hepatocytes*

  2002cited by this paper
• Peripheral metabolic actions of leptin.

  2002cited by this paper
• Transcriptional Profiling Reveals Global Defects in Energy Metabolism, Lipoprotein, and Bile Acid Synthesis and Transport with Reversal by Leptin Treatment in Ob/ob Mouse Liver*

  2001cited by this paper
• Induction of the Phospholipid Transfer Protein Gene Accounts for the High Density Lipoprotein Enlargement in Mice Treated with Fenofibrate*

  2001cited by this paper
• Peroxisome proliferator-activated receptor-α activation and high-density lipoprotein metabolism☆

  2001cited by this paper
• Fenofibrate prevents and reduces body weight gain and adiposity in diet‐induced obese rats

  2001cited by this paper
• Peroxisome proliferator-activated receptor-alpha activation and high-density lipoprotein metabolism.

  2001cited by this paper
• Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway.

  2001cited by this paper
• A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle

  2001cited by this paper
• Peroxisome proliferator-activated receptor alpha activates transcription of the brown fat uncoupling protein-1 gene. A link between regulation of the thermogenic and lipid oxidation pathways in the brown fat cell.

  2001cited by this paper
• The Peroxisome Proliferator-Activated Receptor a Is a Phosphoprotein: Regulation by Insulin.

  2001cited by this paper
• Bezafibrate reduces mRNA levels of adipocyte markers and increases fatty acid oxidation in primary culture of adipocytes.

  2001cited by this paper
• Estradiol increases glucagon's satiating potency in ovariectomized rats.

  2001cited by this paper
• Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice

  2001cited by this paper
• A potent PPARalpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle.

  2001cited by this paper
• Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean

  2000cited by this paper
• Induction of IκBα Expression as a Mechanism Contributing to the Anti-inflammatory Activities of Peroxisome Proliferator-activated Receptor-α Activators*

  2000cited by this paper
• Modulation of estrogen receptor-alpha transcriptional activity by the coactivator PGC-1.

  2000cited by this paper
• Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators.

  2000cited by this paper
• Peroxisome proliferator-activated receptor alpha (PPARalpha) activators, bezafibrate and Wy-14,643, increase uncoupling protein-3 mRNA levels without modifying the mitochondrial membrane potential in primary culture of rat preadipocytes.

  2000cited by this paper
• Induction of IkappaBalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators.

  2000cited by this paper
• Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce Adiposity*

  2000cited by this paper
• The PPARs: from orphan receptors to drug discovery.

  2000cited by this paper
• Skeletal muscle respiratory uncoupling prevents diet-induced obesity and insulin resistance in mice

  2000cited by this paper
• Isolation and Characterization of Peroxisome Proliferator-activated Receptor (PPAR) Interacting Protein (PRIP) as a Coactivator for PPAR*

  2000cited by this paper
• Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.

  2000cited by this paper
• Gonadal steroids and energy homeostasis in the leptin era.

  2000cited by this paper
• Oxidized phospholipids activate PPARalpha in a phospholipase A2-dependent manner.

  2000cited by this paper
• Modulation of Estrogen Receptor-α Transcriptional Activity by the Coactivator PGC-1*

  2000cited by this paper
• Oxidized phospholipids activate PPARα in a phospholipase A2‐dependent manner

  2000cited by this paper
• Estrogen effects on triglyceride metabolism in analbuminemic rats.

  2000cited by this paper
• Pristanic acid and phytanic acid: naturally occurring ligands for the nuclear receptor peroxisome proliferator-activated receptor alpha.

  2000cited by this paper
• Roles of PPARs in health and disease

  2000cited by this paper
• Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats.

  1999cited by this paper
• Regulation of the Transcriptional Activity of the Peroxisome Proliferator-activated Receptor α by Phosphorylation of a Ligand-independent trans-Activating Domain*

  1999cited by this paper
• Peroxisome proliferator-activated receptors: nuclear control of metabolism.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha: role in rodent liver cancer and species differences.

  1999cited by this paper
• Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1*

  1999cited by this paper
• Conjugated linoleic acid is a potent naturally occurring ligand and activator of PPARalpha.

  1999cited by this paper
• Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth.

  1999cited by this paper
• Up-regulation of liver uncoupling protein-2 mRNA by either fish oil feeding or fibrate administration in mice.

  1999cited by this paper
• Orphan nuclear receptors: from gene to function.

  1999cited by this paper
• Genomic organization and mutational analysis of the human UCP2 gene, a prime candidate gene for human obesity.

  1999cited by this paper
• Identification of Nuclear Receptor Corepressor as a Peroxisome Proliferator-activated Receptor α Interacting Protein*

  1999cited by this paper
• Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene.

  1999cited by this paper
• Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging.

  1999cited by this paper
• Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.

  1999cited by this paper
• Orphan nuclear receptors: shifting endocrinology into reverse.

  1999cited by this paper
• Peroxisome proliterator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis

  1999cited by this paper
• Mechanism of action of fibrates on lipid and lipoprotein metabolism.

  1998cited by this paper
• Peroxisome Proliferator-activated Receptor α-Isoform Deficiency Leads to Progressive Dyslipidemia with Sexually Dimorphic Obesity and Steatosis*

  1998cited by this paper
• Peroxisome Proliferator-Activated Receptors γ and α Mediate in Vivo Regulation of Uncoupling Protein (UCP-1, UCP-2, UCP-3) Gene Expression.

  1998cited by this paper

• Puerarin 6″-O-xyloside improves postmenopausal lipid metabolic disorders via the PPARα-mediated FAO pathway.

  2026cites this paper
• Spatially-resolved molecular sex differences at single cell resolution in the adult human ventromedial and arcuate hypothalamus

  2026cites this paper
• Exploring the toxicological mechanisms of reduced fertility in dairy cows due to nonesterified fatty acids on the basis of network toxicology, transcriptomics and molecular docking

  2026cites this paper
• A Schizochytrium sp.-derived lipid-lowering peptide: Optimized enzymatic production, sequence identification, and action mechanism

  2025cites this paper
• Discovery of the first-in-class FABP/PPAR multiple modulator for the treatment of metabolic dysfunction-associated steatohepatitis.

  2025cites this paper
• Polyfluoroalkyl substances and altered glucose homeostasis in adolescents following bariatric surgery

  2025cites this paper
• Per- and poly-fluoroalkyl substances as forever chemicals in drinking water: Unraveling the nexus with obesity and endocrine disruption – A mini review

  2025cites this paper
• Association between prenatal PFAS exposure and catch-up growth in children born with adverse outcomes: evidence from a prospective cohort study.

  2025cites this paper
• Sex-specific association of visceral and abdominal subcutaneous adipose tissue with gastroesophageal reflux disease: a large-scale perspective cohort study

  2025cites this paper
• Sustainable Valorization of Green Tea Waste as a Nutraceutical to Reduce Fat Deposition in Striped Catfish (Pangasianodon Hypophthalmus)

  2025cites this paper
• Human liver perfluorooctane sulfonate associates with steatotic liver disease in a sex-dependent manner.

  2025cites this paper
• Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scores

  2025cites this paper
• Sevoflurane impairs neurogenesis and cognitive function by inhibiting fatty acid β-oxidation in neural stem/progenitor cells of neonatal rats

  2025cites this paper
• Exploring the phytochemical diversity of millets: the path to improved health and disease prevention

  2025cites this paper
• Regulatory effects and mechanisms of exopolysaccharides from Lactococcus lactis Z-2 on lipid metabolism in common carp (Cyprinus carpio) fed a high-fat diet.

  2025cites this paper
• Branched- Chain Fatty Acids and Obesity: A Narrative Review.

  2025cites this paper
• DNA methylation in adaptation to high-altitude environments and pathogenesis of related diseases

  2025cites this paper
• Dietary Coleus Forskohlii Root Powder Reduces Fat Deposition and Improves Fatty Acid Composition in Striped Catfish (Pangasianodon hypophthalmus)

  2025cites this paper
• Dual targeting PPARα and NPC1L1 metabolic vulnerabilities blocks tumorigenesis.

  2025cites this paper
• Rutin alleviates heat stress induced hepatic abnormal lipid metabolism of broilers via improving antioxidant capacity to maintain mitochondrial homeostasis.

  2025cites this paper
• Normalization of Oxygen Levels Induces a Metabolic Reprogramming in Livers Exposed to Intermittent Hypoxia Mimicking Obstructive Sleep Apnea

  2025cites this paper
• Effects of atmospherically relevant PM2.5 on skeletal muscle mitochondria: a review of damage mechanisms and potential of exercise interventions

  2025cites this paper
• Fatty acids as biomarkers of organohalogen contaminant exposure in mangrove insects from the Pearl River Estuary, South China.

  2025cites this paper
• Serum cortisol and AdipoR2 rs12342 were involved in the correlation between stress and serum cholesterol in a gender-specific manner

  2025cites this paper
• Wheat Germ Peptide Ameliorates Hyperglycemia and Hyperlipidemia in Diabetic Rats Through Modulation of Suppressor of Cytokine Signaling‐3/Insulin Receptor Substrate‐1/Protein Kinase B and Lipid Metabolism Pathways

  2025cites this paper
• Role of ZEB1 in immune response, inflammation and membrane remodeling during neoplasia

  2025cites this paper
• Antihyperlipidemic effect and GC-MS analysis of phytoconstituents from Laurus nobilis essential oil in rat

  2024cites this paper
• Neuroinflammation is dependent on sex and ovarian hormone presence following acute woodsmoke exposure

  2024cites this paper
• Disturbed brain energy metabolism in a rodent model of DYT-TOR1A dystonia.

  2024cites this paper
• Lactobacillus plantarum P9 ameliorates dysfunctional immune and metabolic homeostasis along the gut–liver axis in a nonalcoholic fatty liver disease with low-grade colitis mouse model

  2024cites this paper
• Overview of Ethnobotanical–Pharmacological Studies Carried Out on Medicinal Plants from the Serra da Estrela Natural Park: Focus on Their Antidiabetic Potential

  2024cites this paper
• Regulation of Mitochondrial and Peroxisomal Metabolism in Female Obesity and Type 2 Diabetes

  2024cites this paper
• Network pharmacology-based anti-obesity activity of Gavedhuka (a millet): In silico study

  2024cites this paper
• Identification of New Polyacetylenes from Dendropanax morbifera with PPAR-α Activity Study

  2024cites this paper
• The long-chain polyfluorinated alkyl substance perfluorohexane sulfonate (PFHxS) promotes bone marrow adipogenesis.

  2024cites this paper
• Fucoidan alleviates hepatic lipid deposition by modulating the Perk-Eif2α-Atf4 axis via Sirt1 activation in Acanthopagrus schlegelii.

  2024cites this paper
• The effects of saturated and unsaturated fatty acids on MASLD: a Mendelian randomization analysis and in vivo experiment

  2024cites this paper
• Humulus japonicus Extract Ameliorates Hepatic Steatosis Through the PPARα-Mediated Suppression of Alcohol-Induced Oxidative Stress

  2023cites this paper
• Fenofibrate alleviates insulin resistance by reducing tissue inflammation in obese ovariectomized mice

  2023cites this paper
• Olvanil inhibits adipocyte differentiation in 3T3-L1 cells, reduces fat accumulation and improves lipidic profile on mice with diet-induced obesity

  2023cites this paper
• Recent advances in the crosstalk between adipose, muscle and bone tissues in fish

  2023cites this paper
• Origanum Compactum Essential Oil Ameliorates Triton WR-1339-Induced Hyperlipidemia in Rats: Chemical Composition and Acute Toxicity

  2023cites this paper
• Maternal peri-conceptional vitamin B12 deficiency in Wistar rats leads to sex-specific programming for cardiometabolic disease risk in the next generation.

  2023cites this paper
• Dietary zinc levels affect growth, appetite, and lipid metabolism of Chinese perch (Siniperca chuatsi)

  2023cites this paper
• Regulation of poultry lipid metabolism by dietary fibre: a review

  2023cites this paper
• Lipid Aldehydes 4-Hydroxynonenal and 4-Hydroxyhexenal Exposure Differentially Impact Lipogenic Pathways in Human Placenta

  2023cites this paper
• Exposure to novel brominated and organophosphate flame retardants and associations with type 2 diabetes in East China: A case-control study.

  2023cites this paper
• Genome-Wide Gene-Set Analysis Identifies Molecular Mechanisms Associated with ALS

  2023cites this paper
• Unraveling the Crosstalk between Lipids and NADPH Oxidases in Diabetic Kidney Disease

  2023cites this paper
• Bisphenol A has a sex-dependent disruptive effect on hepatic lipid metabolism in zebrafish.

  2023cites this paper
• Effects of differential regional PM2.5 induced hepatic steatosis and underlying mechanism.

  2023cites this paper
• Association of branched-chain fatty acids with metabolic syndrome: a systematic review and meta-analysis of observational studies.

  2023cites this paper
• Modulation of the Microbiome-Fat-Liver Axis by Lactic Acid Bacteria: A Potential Alleviated Role in High-Fat-Diet-Induced Obese Mice.

  2023cites this paper
• MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice

  2023cites this paper
• Peroxisome proliferator-activated receptor-α activation facilitates contextual fear extinction and modulates intrinsic excitability of dentate gyrus neurons

  2023cites this paper
• Effects of Ocimum basilicum mucilage on hyperlipidemia and gut microbiota on mice fed a high-fat diet

  2023cites this paper
• Protective effect of orange essential oil on the formation of non-alcoholic fatty liver disease caused by high-fat diet.

  2022cites this paper
• The immune response as a therapeutic target in non-alcoholic fatty liver disease

  2022cites this paper
• Differences in lipid metabolism in acquired versus preexisting glucose intolerance during gestation: role of free fatty acids and sphingosine-1-phosphate

  2022cites this paper
• Phosphatidylmannoside prevents obesity induced by high-fat feeding

  2022cites this paper
• Organic chromium derived from the chelation of Ganoderma lucidum polysaccharide and chromium (III) alleviates metabolic syndromes and intestinal microbiota dysbiosis induced by high-fat and high-fructose diet.

  2022cites this paper
• Fatty Acids and Eicosanoids Change during High-Fiber Diet in NAFLD Patients—Randomized Control Trials (RCT)

  2022cites this paper
• A multi-layer functional genomic analysis to understand noncoding genetic variation in lipids.

  2022cites this paper
• Molecular mechanisms of metabolic associated fatty liver disease (MAFLD): functional analysis of lipid metabolism pathways

  2022cites this paper
• Oxidative Stress Causes Masculinization of Genetically Female Medaka Without Elevating Cortisol

  2022cites this paper
• Association of Leu432Val (rs1056836) polymorphism of the CYP1B1 gene with lipid profile in hypertensive Slovak women

  2022cites this paper
• Effects of Dietary Lipid Levels on the Lipid Deposition and Metabolism of Subadult Triploid Rainbow Trout (Oncorhynchus mykiss)

  2022cites this paper
• Emerging Role of Hepatic Ketogenesis in Fatty Liver Disease

  2022influential citation
• Hepatocyte Thorns, A Novel Drug-Induced Stress Response in Human and Mouse Liver Spheroids

  2022cites this paper
• Physicochemical and Biochemical Evaluation of Amorphous Solid Dispersion of Naringenin Prepared Using Hot-Melt Extrusion

  2022cites this paper
• Transcriptomic Analysis and Histological Alteration of Black Sea Bream (Acanthopagrus schlegelii) Liver Fed Different Protein/Energy Ratio Diets

  2022cites this paper
• Lactobacillus plantarum ZY08 relieves chronic alcohol-induced hepatic steatosis and liver injury in mice via restoring intestinal flora homeostasis.

  2022cites this paper
• Fatty Acid Incorporation in the Muscle, Oxidative Markers, Lipid Peroxidation and PPAR-α and SREBP-2 Expression of Zebrafish Fed Linseed Oil and Clove Leaf Essential Oil.

  2022cites this paper
• WY-14643 attenuates lipid deposition via activation of the PPARα/CPT1A axis by targeting Gly335 to inhibit cell proliferation and migration in ccRCC

  2022cites this paper
• A single factor elicits multilineage reprogramming of astrocytes in the adult mouse striatum

  2022cites this paper
• Effects of dietary berberine on growth performance, lipid metabolism, antioxidant capacity and lipometabolism-related genes expression of AMPK signaling pathway in juvenile black carp (Mylopharyngodon piceus) fed high-fat diets

  2022cites this paper
• Serum cholesterol and the risk of developing hormonally driven cancers: A narrative review

  2022cites this paper
• Sexual dimorphism: increased sterol excretion leads to hypocholesterolaemia in female hyperbilirubinaemic Gunn rats

  2022cites this paper
• The Ameliorative Effect and Mechanisms of Ruditapes philippinarum Bioactive Peptides on Obesity and Hyperlipidemia Induced by a High-Fat Diet in Mice

  2022cites this paper
• Transcriptome signature changes in the liver of a migratory passerine.

  2022cites this paper
• Nischarin Deletion Reduces Oxidative Metabolism and Overall ATP: A Study Using a Novel NISCHΔ5-6 Knockout Mouse Model

  2022cites this paper
• A biologically based model to quantitatively assess the role of the nuclear receptors liver X (LXR), and pregnane X (PXR) on chemically induced hepatic steatosis.

  2022cites this paper
• Vitamin C status and its change in relation to glucose-lipid metabolism in overweight and obesity patients following laparoscopic sleeve gastrectomy

  2022cites this paper
• Camel milk protein hydrosylate alleviates hepatic steatosis and hypertension in high fructose-fed rats

  2022cites this paper
• The G-Protein-Coupled Estrogen Receptor Agonist Prevents Cardiac Lipid Accumulation by Stimulating Cardiac Peroxisome Proliferator-Activated Receptor α: A Preclinical Study in Ovariectomized-Diabetic Rat Model

  2022cites this paper
• The Synergistic Protective Effect of γ-Oryzanol (OZ) and N-Acetylcysteine (NAC) against Experimentally Induced NAFLD in Rats Entails Hypoglycemic, Antioxidant, and PPARα Stimulatory Effects

  2022cites this paper
• Adipose-Specific PPARα Knockout Mice Have Increased Lipogenesis by PASK–SREBP1 Signaling and a Polarity Shift to Inflammatory Macrophages in White Adipose Tissue

  2021cites this paper
• Urate-lowering drugs in the treatment of gout: The unknown about the known

  2021cites this paper
• Relevance of Peroxisome Proliferator Activated Receptors in Multitarget Paradigm Associated with the Endocannabinoid System

  2021cites this paper
• Ganoderma lucidum protease hydrolyzate on lipid metabolism and gut microbiota in high-fat diet fed rats

  2021cites this paper
• Impact of brominated flame retardants on lipid metabolism: An in vitro approach.

  2021cites this paper
• New insights on association between circadian rhythm and lipid metabolism in spontaneously hypertensive rats.

  2021cites this paper
• Benefits of Polyphenols and Methylxanthines from Cocoa Beans on Dietary Metabolic Disorders

  2021cites this paper
• Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced Atherosclerosis

  2021cites this paper
• CYP2E1 in Alcoholic and Non-Alcoholic Liver Injury. Roles of ROS, Reactive Intermediates and Lipid Overload

  2021cites this paper
• Silybin alleviates hepatic lipid accumulation in methionine-choline deficient diet-induced nonalcoholic fatty liver disease in mice via peroxisome proliferator-activated receptor α.

  2021cites this paper
• Effect of cold stress on the MAPK pathway and lipidomics on muscle of Takifugu fasciatus

  2021cites this paper
• Protective Effects of A. sativa against Oxidative Stress-Induced Liver Damage in Ovariectomized Mice

  2021cites this paper
• Dietary Inflammatory Index and Breast Cancer: report from a Large-Scale Case-Control Study

  2021cites this paper
• Artificial Sweeteners: History and New Concepts on Inflammation

  2021cites this paper